SIGN UP FOR UPDATES!
Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
ENGLEMED
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BOOKS AND GIFTS THIS WAY!
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
SEARCH THIS SITE
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
FreeDigitalPhotos
www.freedigitalphotos.net
FreeWebPhotos
www.freewebphoto.com
FROM OUR NEWS FEEDS
Malaria science advances amid eradication pessimism
Fri August 23rd - British scientists have unveiled major discoveries about malaria – as the World Health Organisation warned the disease would not be eradicated in the near future. More
Polypill success at preventing cardiovascular diseases
Fri August 23rd - A low-cost polypill, which combines four cardiovascular drugs into a single pill, has cut the risk of major cardiovascular events in the first trial of its kind, researchers report today. More
Half hour daily activity backed in new analysis
Fri August 23rd - People who undertake daily physical activity, regardless of intensity, may gain the optimal health benefits, researchers have reported. More
RECENT COMMENTS
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote:
https://epidemicj17.imascientist.org.uk/2017/06/21... on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...
BOOKS ON CHILDREN'S HEALTH
For books, child safety and gift ideas click here
NEWS FEEDS
ENGLEMED HEALTH NEWS

Cure claim for SCID gene therapy

Thursday April 18th, 2019

Gene therapy developed for babes with severe combined immunodeficiency may have successfully "cured" all of those who received treatment, doctors claimed last night.

Eight infants now have fully functioning immune systems and are living normal lives, US researchers reported in the New England Journal of Medicine.

Not one of the children has developed a life-threatening infection since the treatment and normal numbers of multiple types of immune cell developed within four months of gene therapy in seven cases, the researchers report.

The doctor who led the project, Dr Brian Sorrentino, St. Jude Children's Research Hospital, Tennessee, USA, died after compiling the latest findings and submitting them for publication late last year.

His colleague Dr Ewelina Mamcarz said: "These patients are toddlers now, who are responding to vaccinations and have immune systems to make all immune cells they need for protection from infections as they explore the world and live normal lives.

"This is a first for patients with SCID-X1."

The treatment involved inserting a correct copy of the IL2RG gene into the genome of patient blood stem cells. The cells were frozen and tested before being returned to the patients.

Before undergoing the autologous stem cell transplant, the babies received two days of low-dose busulfan to make space for the treated cells. One patient needed a second dose of therapy.

The viral vector has "insulators" included to prevent activation of neighbouring genes and reduce the risk of triggering leukaemia.

The doctors said they expected most patients to experience "a complete durable immune response without side effects."

Dr Anthony Fauci, director of the US National Institute of Allergy and Infectious Diseases, said: "These exciting new results suggest that gene therapy may be an effective treatment option for infants with this extremely serious condition, particularly those who lack an optimal donor for stem cell transplant.

"This advance offers them the hope of developing a wholly functional immune system and the chance to live a full, healthy life."

NEJM 18 April 2019

https://www.nejm.org/doi/full/10.1056/NEJMoa1815408

Tags: Child Health | Genetics | UK News

Printer friendly page Printer friendly page

Comment on this article:

Name:
Email:
Comment:
<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)
CATEGORIES